The Effect of a Carbohydrate Drink on Cognitive Function and Exercise Performance

NCT ID: NCT02045342

Last Updated: 2014-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will investigate the effects of hydrothermally modified starch (SuperStarch) in adults. SuperStarch, originally developed as a drink for children with glycogen storage disease, is a slow digestible carbohydrate, maintaining blood sugar levels over extended periods. Therefore, it could be beneficial to exercise and mental performance, and could possibly have fat loss effects by increasing feelings of fullness. In this study, measures will be taken in 25 men to assess mental function, appetite, and metabolism to determine the processes involved in possible fat loss.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Carbohydrate drink

Ingest 500ml (1g/kg) prior to metabolic measures.

Group Type EXPERIMENTAL

Carbohydrate drink

Intervention Type OTHER

Ingest 500ml (1g/kg) prior to metabolic measures.

Placebo

Intervention Type OTHER

Ingest 500ml of placebo prior to metabolic measures.

Placebo

Ingest 500ml of placebo prior to metabolic measures.

Group Type PLACEBO_COMPARATOR

Carbohydrate drink

Intervention Type OTHER

Ingest 500ml (1g/kg) prior to metabolic measures.

Placebo

Intervention Type OTHER

Ingest 500ml of placebo prior to metabolic measures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Carbohydrate drink

Ingest 500ml (1g/kg) prior to metabolic measures.

Intervention Type OTHER

Placebo

Ingest 500ml of placebo prior to metabolic measures.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy, 18 to 35 year old man or woman.

Exclusion Criteria

* smoker
* pregnancy
* taking part in other research.
* followed a weight loss diet in the previous 6 months.
* history of gastrointestinal, endocrine, cardiovascular disease or diabetes.
* neurological or psychiatric condition that may cause cognitive dysfunction.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Western Ontario, Canada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Exercise Nutrition Research Laboratory, Western University

London, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Peter Lemon, PhD

Role: CONTACT

519 661 2111 ext. 88139

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Peter Lemon, PhD

Role: primary

519 661 2111 ext. 88139

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

104111

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Carbohydrates
NCT03242122 COMPLETED NA
Evaluation of Carbohydrates Part 2
NCT03293706 COMPLETED NA
Cellodextrin Tolerability Study
NCT02621086 COMPLETED NA